Perrot, A., Lambert, J., Hulin, C., Pieragostini, A., Karlin, L., Arnulf, B., Rey, P., Garderet, L., Macro, M., Escoffre-Barbe, M., Gay, J., Chalopin, T., Gounot, R., Schiano, J., Mohty, M., Leleu, X., Manier, S., Mariette, C., Chaleteix, C., Braun, T., Prijck, B. D., Avet-Loiseau, H., Mary, J., Corre, J., Moreau, P., Touzeau, C. (2025). Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2505133